Prevention and treatment of exacerbations of non-CF bronchiectasis

Jessica Rademacher, Felix C. Ringshausen

Source: Eur Respir Monogr 2013; 60: 127-136

Journal Issue: The Spectrum of Bronchial Infection

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jessica Rademacher, Felix C. Ringshausen. Prevention and treatment of exacerbations of non-CF bronchiectasis. Eur Respir Monogr 2013; 60: 127-136

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010
Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011
Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006
Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013
COPD exacerbations in old age: how to prevent, detect and treat Source: Eur Respir Mon; 2009: 43: 90–110 Year: 2009
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Assessing response to treatment of exacerbations of bronchiectasis in adults Source: Eur Respir J 2009; 33: 312-318 Year: 2009
Mechanisms of exacerbation of respiratory symptoms in patients with COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
Use of antibiotics, antioxidants, mucolytics and vaccines in the therapy of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=296 Year: 2006
Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Prevention and treatment of COPD exacerbations Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations Year: 2018
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009
Modulation of airway inflammation to prevent exacerbations of COPD Source: Eur Respir Rev 2005; 14: 78-82 Year: 2005
Telithromycin for acute exacerbations of asthma: pulmonary function data from the TELICAST study Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013
Treatment to prevent exacerbations in bronchiectasis: macrolides as first line? Source: Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019 Year: 2019
Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Effect of different asthma treatments on risk of cold-related exacerbations Source: Eur Respir J 2011; 38: 584-593 Year: 2011
Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016